GlassScriptPhysician profile
Micah Lee Mccarty
NPI 1013645670
$1,257.01
in general payments reported to CMS, 2019-2025
15 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $149 · 2023: $402 · 2024: $290 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $220.59 | 2023-2025 | Syfovre |
| Alcon Vision LLC | $196.89 | 2023-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Abbvie INC. | $182.28 | 2025 | |
| Sight Sciences, INC. | $148.74 | 2022-2023 | Tearcare System |
| Glaukos Corporation | $136.32 | 2023-2025 | Idosetr, Idose |
| Rxsight INC | $96.44 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $56.86 | 2024-2025 | Scoutpro Osmolarity System, Xiidra, Miebo |
| Ocular Therapeutix, INC. | $45.63 | 2024 | Dextenza |
| Coopervision INC. | $33.26 | 2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $31.19 | 2023 | Cequa |
| Mallinckrodt Hospital Products INC. | $26.50 | 2025 | Acthar |
| Johnson & Johnson Vision Care, INC. | $24.15 | 2025 | |
| Coherus Oncology, INC. | $21.21 | 2022 | |
| Harrow Eye, LLC | $20.06 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $16.89 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.